BX795-Organic Acid Coevaporates: Evaluation of Solid-State Characteristics, In Vitro Cytocompatibility and In Vitro Activity against HSV-1 and HSV-2.
Autorzy:
Sutar Y; Department of Pharmaceutical Sciences, The Daniel K. Inouye College of Pharmacy, University of Hawaii Hilo, Hilo, HI 96720, USA. Yadavalli T; Department of Ophthalmology and Visual Sciences, University of Illinois at Chicago, Chicago, IL 60612, USA. Paul SK; Department of Pharmaceutical Sciences, Creighton University School of Pharmacy and Health Profession, 2200 California Plaza, Omaha, NE 68710, USA. Mallick S; Department of Pharmaceutical Sciences, The Daniel K. Inouye College of Pharmacy, University of Hawaii Hilo, Hilo, HI 96720, USA. Koganti R; Department of Ophthalmology and Visual Sciences, University of Illinois at Chicago, Chicago, IL 60612, USA. Chauhan H; Department of Pharmaceutical Sciences, Creighton University School of Pharmacy and Health Profession, 2200 California Plaza, Omaha, NE 68710, USA. DateAA; Department of Pharmaceutical Sciences, The Daniel K. Inouye College of Pharmacy, University of Hawaii Hilo, Hilo, HI 96720, USA.; Department of Tropical Medicine, Medical Microbiology and Pharmacology, John A. Burns School of Medicine, University of Hawaii Manoa, Honolulu, HI 96813, USA. Shukla D; Department of Ophthalmology and Visual Sciences, University of Illinois at Chicago, Chicago, IL 60612, USA.; Department of Microbiology and Immunology, University of Illinois at Chicago, Chicago, IL 60612, USA.
Pokaż więcej
Źródło:
Pharmaceutics [Pharmaceutics] 2021 Nov 12; Vol. 13 (11). Date of Electronic Publication: 2021 Nov 12.
DJ4 Targets the Rho-Associated Protein Kinase Pathway and Attenuates Disease Progression in Preclinical Murine Models of Acute Myeloid Leukemia.
Autorzy:
Golla U; Department of Medicine, Division of Hematology and Oncology, Pennsylvania State University College of Medicine, Hershey, PA 17033, USA.; Penn State Cancer Institute, Pennsylvania State University College of Medicine, Hershey, PA 17033, USA. Ehudin MA; Division of Hematology and Oncology, Department of Pediatrics, Pennsylvania State University College of Medicine, Hershey, PA 17033, USA. Annageldiyev C; Department of Medicine, Division of Hematology and Oncology, Pennsylvania State University College of Medicine, Hershey, PA 17033, USA.; Penn State Cancer Institute, Pennsylvania State University College of Medicine, Hershey, PA 17033, USA. Zeng Z; Department of Pharmacology, Pennsylvania State University College of Medicine, Hershey, PA 17033, USA. Bastihalli Tukaramrao D; Division of Hematology and Oncology, Department of Pediatrics, Pennsylvania State University College of Medicine, Hershey, PA 17033, USA. Tarren A; Department of Medicine, Division of Hematology and Oncology, Pennsylvania State University College of Medicine, Hershey, PA 17033, USA.; Penn State Cancer Institute, Pennsylvania State University College of Medicine, Hershey, PA 17033, USA. DateAA; The Daniel K. Inouye College of Pharmacy, University of Hawaii, Hilo, HI 96720, USA. Elcheva I; Division of Hematology and Oncology, Department of Pediatrics, Pennsylvania State University College of Medicine, Hershey, PA 17033, USA. Berg A; Penn State Cancer Institute, Pennsylvania State University College of Medicine, Hershey, PA 17033, USA. Amin S; Penn State Cancer Institute, Pennsylvania State University College of Medicine, Hershey, PA 17033, USA.; Department of Pharmacology, Pennsylvania State University College of Medicine, Hershey, PA 17033, USA. Loughran TP Jr; Department of Medicine, Division of Hematology and Oncology, University of Virginia School of Medicine, Charlottesville, VA 22903, USA.; Department of Medicine, Division of Hematology and Oncology, University of Virginia Cancer Center, Charlottesville, VA 22903, USA. Kester M; Department of Pharmacology, Pennsylvania State University College of Medicine, Hershey, PA 17033, USA.; Department of Medicine, Division of Hematology and Oncology, University of Virginia Cancer Center, Charlottesville, VA 22903, USA. Desai D; Penn State Cancer Institute, Pennsylvania State University College of Medicine, Hershey, PA 17033, USA.; Department of Pharmacology, Pennsylvania State University College of Medicine, Hershey, PA 17033, USA. Dovat S; Division of Hematology and Oncology, Department of Pediatrics, Pennsylvania State University College of Medicine, Hershey, PA 17033, USA. Claxton D; Department of Medicine, Division of Hematology and Oncology, Pennsylvania State University College of Medicine, Hershey, PA 17033, USA.; Penn State Cancer Institute, Pennsylvania State University College of Medicine, Hershey, PA 17033, USA. Sharma A; Department of Medicine, Division of Hematology and Oncology, Pennsylvania State University College of Medicine, Hershey, PA 17033, USA.; Penn State Cancer Institute, Pennsylvania State University College of Medicine, Hershey, PA 17033, USA.; Department of Pharmacology, Pennsylvania State University College of Medicine, Hershey, PA 17033, USA.
Pokaż więcej
Źródło:
Cancers [Cancers (Basel)] 2021 Sep 29; Vol. 13 (19). Date of Electronic Publication: 2021 Sep 29.
An ion-paired moxifloxacin nanosuspension eye drop provides improved prevention and treatment of ocular infection.
Autorzy:
Josyula A; The Center for Nanomedicine, The Wilmer Eye Institute Johns Hopkins University School of Medicine Baltimore Maryland USA.; Department of Chemical and Biomolecular Engineering Johns Hopkins University Baltimore Maryland USA. Omiadze R; The Center for Nanomedicine, The Wilmer Eye Institute Johns Hopkins University School of Medicine Baltimore Maryland USA.; Department of Ophthalmology, The Wilmer Eye Institute Johns Hopkins University School of Medicine Baltimore Maryland USA. Parikh K; The Center for Nanomedicine, The Wilmer Eye Institute Johns Hopkins University School of Medicine Baltimore Maryland USA.; Department of Ophthalmology, The Wilmer Eye Institute Johns Hopkins University School of Medicine Baltimore Maryland USA.; Department of Biomedical Engineering Johns Hopkins University School of Medicine Baltimore Maryland USA.; Center for Bioengineering Innovation and Design Johns Hopkins University Baltimore Maryland USA. Kanvinde P; The Center for Nanomedicine, The Wilmer Eye Institute Johns Hopkins University School of Medicine Baltimore Maryland USA.; Department of Ophthalmology, The Wilmer Eye Institute Johns Hopkins University School of Medicine Baltimore Maryland USA. Appell MB; The Center for Nanomedicine, The Wilmer Eye Institute Johns Hopkins University School of Medicine Baltimore Maryland USA.; Department of Pharmacology and Molecular Sciences Johns Hopkins University School of Medicine Baltimore Maryland USA. Patel P; Department of Pharmaceutical Sciences, The Daniel K. Inouye College of Pharmacy University of Hawaii Hilo Hawaii USA. Saeed H; Department of Pharmaceutical Sciences, The Daniel K. Inouye College of Pharmacy University of Hawaii Hilo Hawaii USA. Sutar Y; Department of Pharmaceutical Sciences, The Daniel K. Inouye College of Pharmacy University of Hawaii Hilo Hawaii USA. Anders N; The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University Baltimore Maryland USA. He P; The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University Baltimore Maryland USA. McDonnell PJ; Department of Ophthalmology, The Wilmer Eye Institute Johns Hopkins University School of Medicine Baltimore Maryland USA. Hanes J; The Center for Nanomedicine, The Wilmer Eye Institute Johns Hopkins University School of Medicine Baltimore Maryland USA.; Department of Chemical and Biomolecular Engineering Johns Hopkins University Baltimore Maryland USA.; Department of Ophthalmology, The Wilmer Eye Institute Johns Hopkins University School of Medicine Baltimore Maryland USA.; Department of Biomedical Engineering Johns Hopkins University School of Medicine Baltimore Maryland USA.; Department of Pharmacology and Molecular Sciences Johns Hopkins University School of Medicine Baltimore Maryland USA.; The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University Baltimore Maryland USA.; Department of Environmental Health Sciences Johns Hopkins University School of Medicine Baltimore Maryland USA.; Department of Neurosurgery Johns Hopkins University School of Medicine Baltimore Maryland USA. DateAA; The Center for Nanomedicine, The Wilmer Eye Institute Johns Hopkins University School of Medicine Baltimore Maryland USA.; Department of Ophthalmology, The Wilmer Eye Institute Johns Hopkins University School of Medicine Baltimore Maryland USA.; Department of Pharmaceutical Sciences, The Daniel K. Inouye College of Pharmacy University of Hawaii Hilo Hawaii USA.; Department of Tropical Medicine, Medical Microbiology and Pharmacology, John A. Burns School of Medicine University of Hawaii Manoa Honolulu Hawaii USA. Ensign LM; The Center for Nanomedicine, The Wilmer Eye Institute Johns Hopkins University School of Medicine Baltimore Maryland USA.; Department of Chemical and Biomolecular Engineering Johns Hopkins University Baltimore Maryland USA.; Department of Ophthalmology, The Wilmer Eye Institute Johns Hopkins University School of Medicine Baltimore Maryland USA.; Department of Biomedical Engineering Johns Hopkins University School of Medicine Baltimore Maryland USA.; Department of Pharmacology and Molecular Sciences Johns Hopkins University School of Medicine Baltimore Maryland USA.; The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University Baltimore Maryland USA.; Department of Gynecology and Obstetrics and Division of Infectious Diseases Johns Hopkins University School of Medicine Baltimore Maryland USA.
Pokaż więcej
Źródło:
Bioengineering & translational medicine [Bioeng Transl Med] 2021 Jun 22; Vol. 6 (3), pp. e10238. Date of Electronic Publication: 2021 Jun 22 (Print Publication: 2021).
Ion-Complex Microcrystal Formulation Provides Sustained Delivery of a Multimodal Kinase Inhibitor from the Subconjunctival Space for Protection of Retinal Ganglion Cells.
Autorzy:
Hsueh HT; Center for Nanomedicine at the Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, MD 21231, USA.; Department of Chemical & Biomolecular Engineering, Johns Hopkins University, Baltimore, MD 21218, USA. Kim YC; Center for Nanomedicine at the Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, MD 21231, USA.; Department of Ophthalmology, Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA. Pitha I; Center for Nanomedicine at the Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, MD 21231, USA.; Department of Ophthalmology, Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA. Shin MD; Center for Nanomedicine at the Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, MD 21231, USA.; Department of Ophthalmology, Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA. Berlinicke CA; Department of Ophthalmology, Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA. Chou RT; Department of Computational Biology, Bioinformatics, and Genomics, Center for Bioinformatics and Computational Biology, University of Maryland, College Park, MD 20742, USA. Kimball E; Department of Ophthalmology, Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA. Schaub J; Department of Ophthalmology, Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA. Quillen S; Department of Ophthalmology, Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA. Leo KT; Center for Nanomedicine at the Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, MD 21231, USA.; Department of Biomedical Engineering, Johns Hopkins University, Baltimore, MD 21218, USA. Han H; Center for Nanomedicine at the Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, MD 21231, USA.; Department of Ophthalmology, Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA. Xiao A; Center for Nanomedicine at the Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, MD 21231, USA.; Department of Biomedical Engineering, Johns Hopkins University, Baltimore, MD 21218, USA. Kim Y; Center for Nanomedicine at the Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, MD 21231, USA.; Department of Biophysics, Johns Hopkins University, Baltimore, MD 21218, USA. Appell M; Center for Nanomedicine at the Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, MD 21231, USA.; Department of Pharmacology and Molecular Sciences, Johns Hopkins University, Baltimore, MD 21287, USA. Rai U; Center for Nanomedicine at the Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, MD 21231, USA.; Department of Ophthalmology, Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA. Kwon H; Center for Nanomedicine at the Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, MD 21231, USA.; Department of Chemical & Biomolecular Engineering, Johns Hopkins University, Baltimore, MD 21218, USA. Kolodziejski P; Center for Nanomedicine at the Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, MD 21231, USA.; Department of Chemical & Biomolecular Engineering, Johns Hopkins University, Baltimore, MD 21218, USA. Ogunnaike L; Center for Nanomedicine at the Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, MD 21231, USA.; Department of Chemical & Biomolecular Engineering, Johns Hopkins University, Baltimore, MD 21218, USA. Anders NM; The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD 21287, USA. Hemingway A; The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD 21287, USA. Jefferys JL; Department of Ophthalmology, Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA. DateAA; Center for Nanomedicine at the Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, MD 21231, USA.; Department of Ophthalmology, Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA. Eberhart C; Center for Nanomedicine at the Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, MD 21231, USA.; Department of Ophthalmology, Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA. Johnson TV; Center for Nanomedicine at the Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, MD 21231, USA.; Department of Ophthalmology, Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA. Quigley HA; Center for Nanomedicine at the Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, MD 21231, USA.; Department of Ophthalmology, Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA. Zack DJ; Center for Nanomedicine at the Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, MD 21231, USA.; Department of Ophthalmology, Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA.; Departments of Neuroscience, Molecular Biology and Genetics, and Genetic Medicine, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA. Hanes J; Center for Nanomedicine at the Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, MD 21231, USA.; Department of Chemical & Biomolecular Engineering, Johns Hopkins University, Baltimore, MD 21218, USA.; Department of Ophthalmology, Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA.; Department of Biomedical Engineering, Johns Hopkins University, Baltimore, MD 21218, USA.; Department of Pharmacology and Molecular Sciences, Johns Hopkins University, Baltimore, MD 21287, USA.; The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD 21287, USA. Ensign LM; Center for Nanomedicine at the Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, MD 21231, USA.; Department of Chemical & Biomolecular Engineering, Johns Hopkins University, Baltimore, MD 21218, USA.; Department of Ophthalmology, Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA.; Department of Biomedical Engineering, Johns Hopkins University, Baltimore, MD 21218, USA.; Department of Pharmacology and Molecular Sciences, Johns Hopkins University, Baltimore, MD 21287, USA.; The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD 21287, USA.; Departments Gynecology and Obstetrics and Infectious Diseases, Johns Hopkins University, Baltimore, MD 21287, USA.
Pokaż więcej
Źródło:
Pharmaceutics [Pharmaceutics] 2021 May 01; Vol. 13 (5). Date of Electronic Publication: 2021 May 01.
Development and evaluation of taste masked dry syrup formulation of potassium chloride.
Autorzy:
Kulkarni M; Department of Pharmaceutics, SCES's Indira College of Pharmacy, 89/2a, Niramay, New Mumbai Pune Highway, Tathawade, Pune, Maharashtra 411033 India. Vishwakarma B; Gansons Ltd, Kolshet Road, Manpada, Thane, Maharashtra 400607 India. Sen S; Gansons Ltd, Kolshet Road, Manpada, Thane, Maharashtra 400607 India. Anupuram S; Department of Pharmaceutics, SCES's Indira College of Pharmacy, 89/2a, Niramay, New Mumbai Pune Highway, Tathawade, Pune, Maharashtra 411033 India. DateAA; 3Department of Pharmaceutical Sciences, The Daniel K. Inouye College of Pharmacy, University of Hawaii Hilo, 200 W. Kawili Street, Hilo, HI 96720 USA.
Pokaż więcej
Źródło:
AAPS open [AAPS Open] 2019; Vol. 5 (1), pp. 1. Date of Electronic Publication: 2019 Jan 22.
Correction: Nanoformulations of Rilpivirine for Topical Pericoital and Systemic Coitus-Independent Administration Efficiently Prevent HIV Transmission.
Nanoformulations of Rilpivirine for Topical Pericoital and Systemic Coitus-Independent Administration Efficiently Prevent HIV Transmission.
Autorzy:
Kovarova M; Division of Infectious Diseases, Center for AIDS Research, University of North Carolina at Chapel Hill, School of Medicine, Chapel Hill, North Carolina, United States of America. Council OD; Division of Infectious Diseases, Center for AIDS Research, University of North Carolina at Chapel Hill, School of Medicine, Chapel Hill, North Carolina, United States of America. DateAA; Department of Pharmacy Practice, Creighton University School of Pharmacy and Health Professions, Omaha, Nebraska, United States of America. Long JM; Division of Infectious Diseases, Center for AIDS Research, University of North Carolina at Chapel Hill, School of Medicine, Chapel Hill, North Carolina, United States of America. Nochi T Belshan M; Department of Pharmacy Practice, Creighton University School of Pharmacy and Health Professions, Omaha, Nebraska, United States of America. Shibata A; Department of Pharmacy Practice, Creighton University School of Pharmacy and Health Professions, Omaha, Nebraska, United States of America. Vincent H; Division of Infectious Diseases, Center for AIDS Research, University of North Carolina at Chapel Hill, School of Medicine, Chapel Hill, North Carolina, United States of America. Baker CE; Division of Infectious Diseases, Center for AIDS Research, University of North Carolina at Chapel Hill, School of Medicine, Chapel Hill, North Carolina, United States of America. Thayer WO; Division of Infectious Diseases, Center for AIDS Research, University of North Carolina at Chapel Hill, School of Medicine, Chapel Hill, North Carolina, United States of America. Kraus G; Janssen Research and Development, Beerse, Belgium. Lachaud-Durand S; Janssen Research and Development, Beerse, Belgium. Williams P; Janssen Research and Development, Beerse, Belgium. Destache CJ; Department of Pharmacy Practice, Creighton University School of Pharmacy and Health Professions, Omaha, Nebraska, United States of America. Garcia JV; Division of Infectious Diseases, Center for AIDS Research, University of North Carolina at Chapel Hill, School of Medicine, Chapel Hill, North Carolina, United States of America.
Pokaż więcej
Źródło:
PLoS pathogens [PLoS Pathog] 2015 Aug 13; Vol. 11 (8), pp. e1005075. Date of Electronic Publication: 2015 Aug 13 (Print Publication: 2015).
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
Development of a standardized screening rule for tuberculosis in people living with HIV in resource-constrained settings: individual participant data meta-analysis of observational studies.
Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies
